Clear Gene Inc.

We've developed an isothermal test for COVID-19 to replace PCR.

COVID-19 Test

Learn more about Clear Gene’s isothermal test for SARS-CoV-2, the virus that causes COVID-19.

Before the pandemic, we used genomics and machine learning to detect residual solid tumor.

Residual disease is cancer that remains after a treatment.

Patients with liquid tumors have benefited from a series of technical revolutions in residual disease detection.

But patients with solid tumors like breast cancer have been left behind. Until now.

We're a group of careful scientists, quietly working behind the scenes to arm those labs on the front lines of patient care.

Life-changing advances require an environment that nurtures unorthodox ideas while simultaneously rewarding methodical product development.

We strive to work along both ends of the innovation spectrum.

Supported by MBC Biolabs